Nitric oxide and oxidative stress is associated with severity of diabetic retinopathy and retinal structural alterations

Clinical and Experimental Ophthalmology

Volumn 43, Issue 5, 2015, Pages 429-436

  Sharma, Shashi ^a   Saxena, Sandeep ^a   Srivastav, Khushboo ^a   Shukla, Rajendra K ^b   Mishra, Nibha ^a   Meyer, Carsten H ^c   Kruzliak, Peter ^d   Khanna, Vinay K ^b  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

^b CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

^c Klinik Pallas   (Switzerland)

^d ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

Author keywords

Diabetic retinopathy; Nitric oxide; Nitrosative stress; Oxidative stress; Spectral domain optical coherence tomography

Indexed keywords

GLUTATHIONE; LIPID PEROXIDE; NITRIC OXIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; DIABETES MELLITUS WITHOUT RETINOPATHY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; INTEROBSERVER CORRELATION; MAJOR CLINICAL STUDY; MALE; NITROSATIVE STRESS; NON-PROLIFERATIVE DIABETIC RETINOPATHY; OBSERVATIONAL STUDY; OXIDATIVE STRESS; PHOTORECEPTOR INNER SEGMENT; PIGMENT EPITHELIUM; PROLIFERATIVE DIABETIC RETINOPATHY; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; VISUAL ACUITY; BLOOD; COMPLICATION; LIPID PEROXIDATION; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OPTICAL COHERENCE TOMOGRAPHY; PATHOLOGY; PATHOPHYSIOLOGY; RETINAL PIGMENT EPITHELIUM; SEVERITY OF ILLNESS INDEX; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; GLUTATHIONE; HUMANS; LIPID PEROXIDATION; LIPID PEROXIDES; MALE; MIDDLE AGED; NITRIC OXIDE; OXIDATIVE STRESS; PROSPECTIVE STUDIES; RETINAL PHOTORECEPTOR CELL INNER SEGMENT; RETINAL PIGMENT EPITHELIUM; SEVERITY OF ILLNESS INDEX; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84937022890     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/ceo.12506     Document Type: Article

References (45)

1. King H, Aurbert I, Herman W. Global burden of diabetes.1995-2025; prevalence, numerical estimates and projections. Diabetes Care 1998; 21: 1414-1431.
2. Ramachandran A, Jali M, Mohan V, Snehlata C, Visawanathan M. High prevalence of diabetes in an urban population in south India. BMJ 1988; 297: 587-590.
3. Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes 1991; 40: 405-412.
4. Feldman E. Oxidative stress and diabetic neuropathy: a new understanding of an old problem. J Clin Invest 2003; 111: 431-433.
5. Kagan V, Shvedova A, Novikov K, Kozlov Y. Light induced free radical oxidation of membrane lipids in photoreceptors of frog retina. Biochim Biophys Acta 1973; 330: 76-79.
6. Roth S. Role of nitric oxide in retinal cell death. Clin Neurosci 1997; 4: 216-223.
7. Goldstein I, Ostwald P, Roth S. Nitric oxide: a review of its role in retinal function and disease. Vision Res 1996; 36: 2979-2994.
8. Kowluru RA, Chan PS. Oxidative stress and diabetic retinopathy. J Diabetes Res 2007; 2007: 43603.
9. Kaji H, Kurasaki M, Ito K etal. Increased lipoperoxide value and glutathione peroxidase activity in blood plasma of type 2 (non-insulin-dependent) diabetic women. Klin Wochenschr 1985; 63: 765-768.
10. Paolisso G, Di Maro G, Pizza G etal. Plasma GSH/GSSG affects glucose homeostasis in healthy subjects and non-insulin-dependent diabetics. Am J Physiol 1992; 263: E435-440.
11. Strauss O. The retinal pigment epithelium in visual function. Physiol Rev 2005; 85: 845-881.
12. Sakamoto A, Nishijima K, Kita M, Oh H, Tsujikawa A, Yoshimura N. Association between foveal photoreceptor status and visual acuity after resolution of diabetic macular edema by pars plana vitrectomy. Graefes Arch Clin Exp Ophthalmol 2009; 247: 1325-1330.
13. Simó R, Carrasco E, García-Ramírez M, Hernández C. Angiogenic and antiangiogenic factors in proliferative diabetic retinopathy. Curr Diabetes Rev 2006; 2: 71-98.
14. Saxena S, Singh K. Three-dimensional retinal imaging in spectral domain optical coherence tomography. In: Saxena S, Sadda S, eds. Emerging Technologies in Retinal Diseases. New Delhi: Jaypee Medical Publishers, 2009; 67-122.
15. Spaide RF, Curcio CA. Human chorioretinal layer thickness as measured in macula - wide, high resolution histologic sections. Retina 2011; 8: 31.
16. Lu RW, Curcio CA, Zhang Y etal. Investigation of the hyper-reflective inner/outer segment band in optical coherence tomography of living frog retina. J Biomed Opt 2012; 17: 1-3.
17. Lattanzio R, Braneto R. Macular thickness measured by OCT in diabetic patients. Eur J Ophthalmol 2002; 12: 1482-1496.
18. Eandi C, Chung J, Cardillo-Piccolino F, Spaide R. Optical coherence tomography in unilateral resolved central serous chorioretinopathy. Retina 2005; 25: 417-421.
19. Murakami T, Tsujikawa A, Ohta M etal. Photoreceptor status after resolved macular edema in branch retinal vein occlusion treated with tissue plasminogen activator. Am J Ophthalmol 2007; 143: 171-173.
20. Piccolino F, de la Longrais R, Ravera G. The foveal photoreceptor layer and visual acuity loss in central serous chorioretinopathy. Am J Ophthalmol 2005; 139: 87-99.
21. Okawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95: 351-358.
22. Hasan M, Haider S. Acetyl homocystein thiolactone protect against some neurotoxic effects of thallium. Neurotoxicology 1989; 10: 257-262.
23. Misko T, Schilling R, Salvemini D, Moore W, Currie M. A fluorometric assay for the measurement of nitrite in biological samples. Anal Biochem 1993; 214: 11-16.
24. Froesch ER, Renold AE, McWilliams B. Specific enzymatic determination of glucose in blood and urine using glucose oxidase. Diabetes 1956; 5: 1-6.
25. StatSoft. STATISTICA 6.0 (data analysis software system). Tulsa: StatSoft, Inc., 2001.
26. Hartnett M, Stratton R, Browne R. Serum markers of oxidative stress and severity of diabetic retinopathy. Diabetes Care 2000; 23: 234-240.
27. Liversidge J, Dick A, Gordon S. Nitric oxide mediates apoptosis through formation of peroxynitrite and Fas/Fas-ligand interactions in experimental autoimmune uveitis. Am J Pathol 2002; 160: 905-916.
28. Wu G-S, Zhang J, Rao NA. Peroxynitrite and oxidative damage in experimental autoimmune uveitis. Invest Ophthalmol Vis Sci 1997; 38: 1333-1339.
29. El-Remmessy AB, Behzadian MA, Abou-Mohamed G, Franklin T, Caldwell RW, Caldwell RB. Experimental diabetes causes breakdown of the blood-retina barrier b y a mechanism involving tyrosine nitration and increases in expression of vascular endothelial growth factor and urokinase plaminogen activator. Am J Pathol 2003; 162: 1995-2004.
30. Shibuki H, Katai N, Yodoi J, Uchida K, Yoshimura N. Lipid peroxidation and peroxynitrite in retinal ischemia-reperfusion injury. Invest Ophthalmol Vis Sci 2000; 41: 3607-3614.
31. Yilmaz G, Peter E, Norbert K. Elevated vitreous nitric oxide levels in patients with proliferative diabetic retinopathy. Am J Ophthalmol 2000; 130: 97-99.
32. Ozden S, Tatlipinar S, Biçer N. Basal serum nitric oxide levels in patients with type 2 diabetes mellitus and different stages of retinopathy. Can J Ophthalmol 2003; 38: 393-396.
33. Izumi N, Nagaoka T, Mori F. Relation between plasma nitric oxide levels and diabetic retinopathy. Jpn J Ophthalmol 2006; 50: 465-468.
34. Pacher P, Obrosova I, Mabley J, Szabó C. Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications, emerging new therapeutical strategies. Curr Med Chem 2005; 12: 267-275.
35. Becquet F, Courtois Y, Goureau O. Nitric oxide decreases in vitro phagocystosis of photoreceptor outer segments by bovine retinal pigmented epithelial cells. J Cell Physiol 1994; 159: 256-262.
36. Yilmaz G, Esser P, Kociek N, Heimann K. Effect of nitric oxide on proliferation of human retina pigment epithelial cells. Eye 2000; 14: 899-902.
37. Hamann S, Zeuthen T, La Cour M etal. Aquaporins in complex tissues distribution of aquaporins 1-5 in human and rat eye. Am J Physiol 1998; 274: 1332-1345.
38. Lerche W. Electron microscopic observations of Bruch's membrane in the human eye. Ber Zusammenkunft Dtsch Ophthalmol Ges 1964; 65: 384-385.
39. Bell E. Experimental studies on the development of the eye and the nasal cavities in frog embryos. Anat Anz 1906; 29: 185-194.
40. Forooghian F, Stetson P, Meyer F, Chew F. Relationship between photoreceptor outer segment length and visual acuity in diabetic macular edema. Retina 2010; 30: 63-70.
41. Maheshwary A, Oster S, Ritchie M, Cheng L, Mojana F, Freeman W. The association between percent disruption of the photoreceptor inner segment-outer segment junction and visual acuity in diabetic macular edema. Am J Ophthalmol 2010; 150: 63-67.
42. Otani T, Yamaguchi Y, Kishi S. Correlation between visual acuity and foveal microstructural changes in diabetic macular edema. Retina 2010; 30: 774-780.
43. Shin H, Lee S, Chung H, Kim H. Association between photoreceptor integrity and visual outcome in diabetic macular edema. Graefes Arch Clin Exp Ophthalmol 2012; 250: 61-70.
44. Jain A, Saxena S, Khanna VK, Shukla RK, Meyer CH. Status of serum VEGF and ICAM-1 and its association with external limiting membrane and inner segment-outer segment junction disruption in type 2 diabetes mellitus. Mol Vis 2013; 19: 1760-1808.
45. Mamputu J, Renier G. Advanced glycation end products increase monocyte adhesion to retinal endothelial cells through vascular endothelial growth factor-induced ICAM-1 expression: inhibitory effect of antioxidants. J Leukoc Biol 2004; 75: 1062-1069.